Search Results 1801-1810 of 20432 for hepatitis

  1. Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations - Mayo Clinic

    Known infection with HIV, or an active infection with hepatitis B or hepatitis C. Received treatment for non-cancer related liver disease (excluding ...

  2. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Participants known to be or having been infected with human immunodeficiency (HIV) virus, hepatitis B virus (HBV), or hepatitis C virus (HCV), and require ...

  3. A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies - Mayo Clinic

    Hepatitis B surface antigen (HbsAg) positive OR Hepatitis B core antibody (anti-HBc or HBcAb) positive and HBV viral load above the lower limit of ...

  4. Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia - Mayo Clinic

    Human immunodeficiency virus positive, active Hepatitis B, or active Hepatitis C. 22. Uncontrolled diabetes mellitus or diabetes mellitus requiring ...

  5. Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy Or Plus Camizestrant In HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, Or PALB2m Advanced Breast Cancer - Mayo Clinic

    * Evidence of active and uncontrolled hepatitis B and/or hepatitis C * Evidence of active and uncontrolled HIV infection * Active tuberculosis infection * ...

  6. Liver transplant - Care at Mayo Clinic

    Related · Acute liver failure · Alcoholic hepatitis (Alcohol-associated hepatitis) · Alpha-1-antitrypsin deficiency · Amyloidosis · Ascites · Autoimmune hepatitis ...

  7. Mayo Clinic Transplant Center - Doctors

    liver disease, Cholangiocarcinoma, Alcoholic hepatitis, Viral hepatitis. Show more areas of focus for Bashar A. Aqel, M.D.. Pagination Doctor search. Go to ...

  8. Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia - Mayo Clinic

    Patients with known hepatitis B or hepatitis C infection may be eligible providing they have viral load < 800,000 IU/mL within 28 days prior to registration ...

  9. Joel Streed | Mayo Clinic News Network - Page 32 of 170

    Viral hepatitis, or inflammation of the liver, is one of the most common infectious diseases in the world. Hundreds of millions of people live with[...].

  10. ARTEMIS - A Research Study To Look At How Ziltivekimab Works Compared To Placebo In People With A Heart Attack - Mayo Clinic

    -Known (acute or chronic) hepatitis B or hepatitis C -History or evidence of untreated latent tuberculosis (TB) such as (but not limited to): a) History of ...